Cromos Pharma sets a new record in site initiation timelines in Poland In the beginning of August 2019, Cromos Pharma has initiated a first site in Poland in a trial that had received a regulatory approval just a couple of weeks earlier! Given the typical timelines in this country, this is a record setting result. This accomplishment is the product of our team’s very hard and coordinated
Cromos Pharma celebrates Breast Cancer Awareness Month Breast cancer is the most commonly occurring cancer in women and the second only to lung cancer as the most common cancer overall. The developed nations in North America and Western Europe lead the world in incidence (well over 60 and up to 95 per 100,000 women ages 0-69). And yet, while mortality rates in
Clinical Trials in Poland: Statistics of the First Half of 2018 Cromos™ Pharma continues with a series of briefs devoted to the clinical trials’ statistics in the geographies of its clinical operations. This brief is focused on Poland and the trials conducted there in the first half of 2018. The data presented in the article is based on the information from ClinicalTrials.gov. Please follow this link to
